一周安徽上市公司要闻回顾（9.29-10.05）

Group 1 - Chipone Microelectronics announced that its actual controller, Cheng Zhuo, plans to reduce holdings by no more than approximately 2.63 million shares, accounting for up to 2% of the total shares [1] - Cheng Zhuo currently holds about 36.79 million shares, representing 27.92% of the company's total share capital [1] - The reduction will occur within three months after the announcement, with specific limits on the number of shares that can be sold through different methods [1] Group 2 - Sier Te announced that former directors and executives are suspected of embezzlement and other crimes, with the company being recognized as involved in unit crime [2] - The allegations include long-term embezzlement of substantial assets and fraudulent activities related to government subsidies [2] - The case has been forwarded to the local prosecutor's office for further investigation [2] Group 3 - Three squirrels received approval from the China Securities Regulatory Commission for the issuance of up to 81.55 million shares for overseas listing [3] - The company must complete the overseas issuance within 12 months of receiving the approval or update its filing materials [3] Group 4 - Chery Group reported sales exceeding 2 million vehicles in the first three quarters, marking a 14.5% year-on-year increase [4] - In September alone, the group sold 280,469 vehicles, a 14.7% increase compared to the previous year [4] - The company continues to lead in China's automotive exports, with 137,624 vehicles exported in September, a 26.2% increase [4] Group 5 - The controlling shareholder of Shanhe Pharmaceutical Auxiliary has changed from Yin Zhenglong to Wu Changhong following the former's passing [5] - Wu Changhong now directly holds 20.172% of the company's shares, while her daughter holds 6.724% [5] - A voting rights delegation agreement has been signed, allowing Wu Changhong to exercise all voting rights [5] Group 6 - Anhui Huaheng Biotechnology submitted a listing application to the Hong Kong Stock Exchange, with Huatai International as the exclusive sponsor [6] Group 7 - Wuzhou Medical announced that its major shareholder, Taihu Honghui, plans to reduce holdings by approximately 1.07 million shares, representing about 1.57% of the total shares [7] - Other executives, including a supervisor and a secretary, also plan to reduce their holdings within the same timeframe [7] Group 8 - Anhui Wanyi Technology received a government subsidy of 1.73 million yuan [8] - The company's revenue composition for 2024 indicates that 94.53% comes from the instrument manufacturing sector [8]